Donna Shaffer

Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults

M. Fay, C. Long, L. Miller, 2010, PloS one.

Phase 1 Study in Malaria Naïve Adults of BSAM2/Alhydrogel®+CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria

M. Fay, C. Long, L. Miller, 2012, PloS one.

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

M. Fay, A. Saul, C. Long, 2008, PloS one.

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.

B. Murphy, K. Subbarao, J. Lindow, 2013, The Journal of infectious diseases.

Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali.

A. Dicko, O. Doumbo, E. Emanuel, 2010, The American journal of tropical medicine and hygiene.

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

B. Murphy, S. Whitehead, J. Blaney, 2011, PLoS neglected tropical diseases.

A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.

M. Fay, A. Saul, C. Long, 2009, Vaccine.

Phase 1 Study in Malaria Naı¨ve Adults of BSAM2/ Alhydrogel H + CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria

Yimin Wu, D. Narum, R. Ellis, 2022 .